HYDREA 500 mg clinical trials

Optimization of the management of drepanocytosis patients treated with hydroxyurea: Interest of the pharmacological therapeutic follow-up

This study is looking at how to give the medicine hydroxyurea more effectively to people with sickle cell disease. It wants to find the best dose to help patients and reduce side effects, making their treatment work better in the long run.